{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-11-16T04:46:35.507901+00:00","published_at":"2026-11-16T04:46:35.507901+00:00","section":"board","data":{"state":"PUBLISHED","size":{"value":6,"assertion_class":"alpha_calculated_metric","basis":"Count of published current board seats in this Record. Roster completeness is not asserted.","input_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11"]},"chair":null,"lead_independent_director":null,"ceo_chair_combined":null,"independence":{"value":{"independent_directors":5,"directors_with_determination":6,"published_directors":6,"independent_share":0.833},"assertion_class":"alpha_calculated_metric","basis":"Board independence determinations are source facts; the share is computed only over directors with a published determination.","input_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11"]},"average_tenure_years":{"value":{"years":12.9,"directors_with_start_date":6},"assertion_class":"alpha_calculated_metric","basis":"Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.","input_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11"]},"committee_load":{"value":{"average_memberships":2.8,"directors_with_memberships":5},"assertion_class":"alpha_calculated_metric","basis":"Average published committee memberships per current director with at least one published membership.","input_claim_ids":["alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11"]},"skills_coverage":null,"directors":[{"person":{"alpha_id":"alpha:person:daniel-hume","name":"Daniel Hume","canonical_url":"https://registry.alpha.ac/people/daniel-hume"},"current_role":"Director","director_since":"2015-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2015-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:daniel-hume","name":"Daniel Hume","canonical_url":"https://registry.alpha.ac/people/daniel-hume"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:14","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:daniel-hume","name":"Daniel Hume","canonical_url":"https://registry.alpha.ac/people/daniel-hume"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit-nominating-and-governance","committee_name":"Audit; Nominating and Governance","role":"member","valid_from":"2015-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:daniel-hume","name":"Daniel Hume","canonical_url":"https://registry.alpha.ac/people/daniel-hume"},"committee_id":"alpha:committee:tg-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:22","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman","canonical_url":"https://registry.alpha.ac/people/kenneth-hoberman"},"current_role":"Director","director_since":"2014-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2014-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman","canonical_url":"https://registry.alpha.ac/people/kenneth-hoberman"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:14","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman","canonical_url":"https://registry.alpha.ac/people/kenneth-hoberman"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit-compensation-chair","committee_name":"Audit; Compensation · Chair","role":"member","valid_from":"2014-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman","canonical_url":"https://registry.alpha.ac/people/kenneth-hoberman"},"committee_id":"alpha:committee:tg-therapeutics-inc:compensation","committee_name":"Compensation","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:19","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Compensation"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:laurence-n-charney","name":"Laurence N. Charney","canonical_url":"https://registry.alpha.ac/people/laurence-n-charney"},"current_role":"Director","director_since":"2012-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2012-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:laurence-n-charney","name":"Laurence N. Charney","canonical_url":"https://registry.alpha.ac/people/laurence-n-charney"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit","committee_name":"Audit","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:14","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:laurence-n-charney","name":"Laurence N. Charney","canonical_url":"https://registry.alpha.ac/people/laurence-n-charney"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit-chair","committee_name":"Audit · Chair","role":"member","valid_from":"2012-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Audit"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:michael-s-weiss","name":"Michael S. Weiss","canonical_url":"https://registry.alpha.ac/people/michael-s-weiss"},"current_role":"Director","director_since":"2011-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2011-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:sagar-lonial","name":"Sagar Lonial","canonical_url":"https://registry.alpha.ac/people/sagar-lonial"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:sagar-lonial","name":"Sagar Lonial","canonical_url":"https://registry.alpha.ac/people/sagar-lonial"},"committee_id":"alpha:committee:tg-therapeutics-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:19","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:sagar-lonial","name":"Sagar Lonial","canonical_url":"https://registry.alpha.ac/people/sagar-lonial"},"committee_id":"alpha:committee:tg-therapeutics-inc:compensation-nominating-and-governance-chair","committee_name":"Compensation; Nominating and Governance · Chair","role":"member","valid_from":"2020-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:sagar-lonial","name":"Sagar Lonial","canonical_url":"https://registry.alpha.ac/people/sagar-lonial"},"committee_id":"alpha:committee:tg-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:22","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Nominating and Governance"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yann-echelard","name":"Yann Echelard","canonical_url":"https://registry.alpha.ac/people/yann-echelard"},"current_role":"Director","director_since":"2012-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2012-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:yann-echelard","name":"Yann Echelard","canonical_url":"https://registry.alpha.ac/people/yann-echelard"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:14","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yann-echelard","name":"Yann Echelard","canonical_url":"https://registry.alpha.ac/people/yann-echelard"},"committee_id":"alpha:committee:tg-therapeutics-inc:audit-nominating-and-governance","committee_name":"Audit; Nominating and Governance","role":"member","valid_from":"2012-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yann-echelard","name":"Yann Echelard","canonical_url":"https://registry.alpha.ac/people/yann-echelard"},"committee_id":"alpha:committee:tg-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:22","evidence_ids":["alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684"],"assertion_class":"source_fact","verification_state":"source_reported"}],"fields_not_published":["chair","lead_independent_director","board_type","median_tenure","average_age","refreshment_rate","gender_diversity","geographic_diversity","succession_risk","overboarding","board_interlocks","attendance"]},"claims":[{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:6","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-hume","object_label":"Daniel Hume","object_source_name_forms":[],"value":"Daniel Hume: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daniel-hume","name":"Daniel Hume"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:7","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kenneth-hoberman","object_label":"Kenneth Hoberman","object_source_name_forms":[],"value":"Kenneth Hoberman: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:8","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:laurence-n-charney","object_label":"Laurence N. Charney","object_source_name_forms":[],"value":"Laurence N. Charney: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:laurence-n-charney","name":"Laurence N. Charney"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:9","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-s-weiss","object_label":"Michael S. Weiss","object_source_name_forms":[],"value":"Michael S. Weiss: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-s-weiss","name":"Michael S. Weiss"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2011-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2011-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2011-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:10","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sagar-lonial","object_label":"Sagar Lonial","object_source_name_forms":[],"value":"Sagar Lonial: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sagar-lonial","name":"Sagar Lonial"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:leadership_role:11","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yann-echelard","object_label":"Yann Echelard","object_source_name_forms":[],"value":"Yann Echelard: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yann-echelard","name":"Yann Echelard"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2012-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2012-01-01","valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2012-01-01","effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"unconfirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:14","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Laurence N. Charney; Members Laurence N. Charney (Chair); Daniel Hume; Kenneth Hoberman; Yann Echelard","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Laurence N. Charney","members":[{"display_name":"Laurence N. Charney","person_slug":"laurence-n-charney","is_chair":true},{"display_name":"Daniel Hume","person_slug":"daniel-hume","is_chair":false},{"display_name":"Kenneth Hoberman","person_slug":"kenneth-hoberman","is_chair":false},{"display_name":"Yann Echelard","person_slug":"yann-echelard","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:19","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Kenneth Hoberman; Members Kenneth Hoberman (Chair); Sagar Lonial","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Kenneth Hoberman","members":[{"display_name":"Kenneth Hoberman","person_slug":"kenneth-hoberman","is_chair":true},{"display_name":"Sagar Lonial","person_slug":"sagar-lonial","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a:committee_record:22","subject_id":"alpha:company:4a7678c3-443e-4b39-93a6-fb8b2f522c3a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Sagar Lonial; Members Sagar Lonial (Chair); Daniel Hume; Yann Echelard","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Sagar Lonial","members":[{"display_name":"Sagar Lonial","person_slug":"sagar-lonial","is_chair":true},{"display_name":"Daniel Hume","person_slug":"daniel-hume","is_chair":false},{"display_name":"Yann Echelard","person_slug":"yann-echelard","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-11-16T04:46:35.507901+00:00","sources":[{"id":"alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:04704f58f798c648812a86686ec3cc57d05090453dee7fdd5d38c029f14d0684","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"TG Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-05-03T19:25:02.108+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:74072c167181bb3ae6f93bea2ca68aeeff8642ca250463887eff2c35f7fdf22d","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925013860/tgtx20250423_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.829,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.471},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-11-16T04:46:35.507901+00:00","observed_at":"2026-11-16T04:46:35.507901+00:00","reviewed_at":"2026-11-16T04:46:35.507901+00:00","verified_at":"2026-11-16T04:46:35.507901+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/tg-therapeutics-inc/board","section":"board","href":"https://registry.alpha.ac/api/public/companies/tg-therapeutics-inc?format=record&section=board","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}